ArticleScience advances2023

An AAV-CRISPR/Cas9 strategy for gene editing across divergent rodent species: Targeting neural oxytocin receptors as a proof of concept.

Arjen J Boender et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.